Nasdaq:AARD – SPAC Feed

Nasdaq:AARD
TEMPISIN1234

February 12, 2025

Aardvark Therapeutics Announces Pricing of Initial Public Offering

SAN DIEGO, Feb. 12, 2025 (GLOBE NEWSWIRE) — Aardvark Therapeutics, Inc. (“Aardvark”) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to…

By sf-admin